Sort by

Send to

Choose Destination

Links from PubMed

Items: 20


Down-regulating cyclin-dependent kinase 9 of alloreactive CD4+ T cells prolongs allograft survival.

Zhan Y, Han Y, Sun H, Liang T, Zhang C, Song J, Hou G.

Oncotarget. 2016 May 3;7(18):24983-94. doi: 10.18632/oncotarget.8804.


Overview of CDK9 as a target in cancer research.

Morales F, Giordano A.

Cell Cycle. 2016;15(4):519-27. doi: 10.1080/15384101.2016.1138186.


Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia.

Yeh YY, Chen R, Hessler J, Mahoney E, Lehman AM, Heerema NA, Grever MR, Plunkett W, Byrd JC, Johnson AJ.

Oncotarget. 2015 Feb 20;6(5):2667-79.


Regulation of CDK9 activity by phosphorylation and dephosphorylation.

Nekhai S, Petukhov M, Breuer D.

Biomed Res Int. 2014;2014:964964. doi: 10.1155/2014/964964. Review.


RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Corden JL.

Chem Rev. 2013 Nov 13;113(11):8423-55. doi: 10.1021/cr400158h. Review. No abstract available.


Cyclin-dependent kinase 9 links RNA polymerase II transcription to processing of ribosomal RNA.

Burger K, Mühl B, Rohrmoser M, Coordes B, Heidemann M, Kellner M, Gruber-Eber A, Heissmeyer V, Strässer K, Eick D.

J Biol Chem. 2013 Jul 19;288(29):21173-83. doi: 10.1074/jbc.M113.483719.


Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function.

Ramakrishnan R, Liu H, Donahue H, Malovannaya A, Qin J, Rice AP.

Retrovirology. 2012 Oct 30;9:90. doi: 10.1186/1742-4690-9-90.


Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II.

Cheng SW, Kuzyk MA, Moradian A, Ichu TA, Chang VC, Tien JF, Vollett SE, Griffith M, Marra MA, Morin GB.

Mol Cell Biol. 2012 Nov;32(22):4691-704. doi: 10.1128/MCB.06267-11.


Cyclin K-containing kinase complexes maintain self-renewal in murine embryonic stem cells.

Dai Q, Lei T, Zhao C, Zhong J, Tang YZ, Chen B, Yang J, Li C, Wang S, Song X, Li L, Li Q.

J Biol Chem. 2012 Jul 20;287(30):25344-52. doi: 10.1074/jbc.M111.321760.


RNA polymerase II elongation control.

Zhou Q, Li T, Price DH.

Annu Rev Biochem. 2012;81:119-43. doi: 10.1146/annurev-biochem-052610-095910. Review.


Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway.

Ramakrishnan R, Rice AP.

J Cell Physiol. 2012 Feb;227(2):609-17. doi: 10.1002/jcp.22760.


A role for CDK9-cyclin K in maintaining genome integrity.

Yu DS, Cortez D.

Cell Cycle. 2011 Jan 1;10(1):28-32. Review.


55K isoform of CDK9 associates with Ku70 and is involved in DNA repair.

Liu H, Herrmann CH, Chiang K, Sung TL, Moon SH, Donehower LA, Rice AP.

Biochem Biophys Res Commun. 2010 Jun 25;397(2):245-50. doi: 10.1016/j.bbrc.2010.05.092.


P-TEFb- the final frontier.

Kohoutek J.

Cell Div. 2009 Sep 2;4:19. doi: 10.1186/1747-1028-4-19.


Role of cdk9 in the optimization of expression of the genes regulated by ICP22 of herpes simplex virus 1.

Durand LO, Roizman B.

J Virol. 2008 Nov;82(21):10591-9. doi: 10.1128/JVI.01242-08.


Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.

Sedore SC, Byers SA, Biglione S, Price JP, Maury WJ, Price DH.

Nucleic Acids Res. 2007;35(13):4347-58.


Pivotal role of cardiac lineage protein-1 (CLP-1) in transcriptional elongation factor P-TEFb complex formation in cardiac hypertrophy.

Espinoza-Derout J, Wagner M, Shahmiri K, Mascareno E, Chaqour B, Siddiqui MA.

Cardiovasc Res. 2007 Jul 1;75(1):129-38.

Items per page

Supplemental Content

Support Center